Description
Heppra (Levetiracetam) 500 mg
Heppra 500 mg is a brand of levetiracetam, an antiepileptic medicine used in the management of certain seizure disorders. It is a prescription medicine with established use in epilepsy, and its exact approved uses can vary by country and product licence.
Active Ingredient and Medicine Class
The verified active ingredient is levetiracetam. It belongs to the anti-seizure (antiepileptic) medicine class and is considered a broad-spectrum antiseizure agent.
Established Medical Uses
Official prescribing information and peer-reviewed reviews describe levetiracetam as being used for partial-onset (focal) seizures and, depending on the authorised product, for some forms of generalized seizures, including myoclonic seizures and primary generalized tonic-clonic seizures associated with idiopathic generalized epilepsy. The exact indication for Heppra should be confirmed from the local product leaflet.
How It Works
Levetiracetam acts differently from many older epilepsy medicines. Scientific evidence shows that it binds to the synaptic vesicle protein SV2A in the brain, which helps regulate the release of neurotransmitters and dampen abnormal electrical activity that can lead to seizures.
Important Safety Information
Levetiracetam is contraindicated in people with known hypersensitivity to levetiracetam. Prescribing information also warns about angioedema and anaphylaxis.
Important precautions include behavioural and psychiatric effects such as irritability, aggression, psychotic symptoms, mood changes, and suicidal thoughts or behaviour. Other clinically significant risks include somnolence, fatigue, dizziness, serious skin reactions, and DRESS/multiorgan hypersensitivity.
Major interaction potential is generally lower than with many older antiseizure medicines, but clinical monitoring remains important because adverse effects and individual response can vary.
Possible Side Effects
Commonly reported adverse effects include sleepiness, fatigue, dizziness, asthenia, and sometimes behavioural changes such as irritability or agitation. Less common but more serious reactions can include rash, allergic swelling, psychosis, and suicidality.
Scientific Evidence
Clinical reviews and meta-analyses support levetiracetam as an effective broad-spectrum antiseizure medicine with a generally favourable tolerability profile. Reviews also note that behavioural adverse effects are an important limitation in some patients, while most other side effects are usually neurological and dose-related.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or individual assessment by a qualified healthcare professional.
Medical Sources
- DailyMed / U.S. prescribing information: LEVETIRACETAM tablet, film coated. View source
- Lyseng-Williamson K. “Levetiracetam: a review of its use in epilepsy.” Drugs (2011). View PubMed article